A mental health care protocol for the screening, detection and treatment of perinatal anxiety and depressive disorders in Flanders by Van Damme, Rita et al.
Contents lists available at ScienceDirect
Journal of Psychosomatic Research
journal homepage: www.elsevier.com/locate/jpsychores
A mental health care protocol for the screening, detection and treatment of
perinatal anxiety and depressive disorders in Flanders
R. Van Dammea, A.-S. Van Parysa, C. Vogelsb, K. Roelensc, G.M.D. Lemmensa,⁎
a Centre for Perinatal Mental Health, Department of Psychiatry, Ghent University Hospital, Ghent, Belgium
bMother-baby Unit, Karus–Campus Ghent, Ghent, Belgium
c Department of Obstetrics and Gynaecology, Ghent University Hospital, Ghent, Belgium
1. Introduction
Perinatal mental health problems are associated with high levels of
psychological and carry a high social and financial burden [1–3]. De-
pressive and anxiety disorders are highly prevalent and they are asso-
ciated with a range of adverse consequences for the mother, the partner
and the offspring [1,2,4]. However, only one in four depressed or an-
xious women are diagnosed and even fewer receive treatment [5]. The
main reasons are due to stigmatization attached to mental health pro-
blems and the lack of recognition of these problems in standard peri-
natal care [5–7].
Therefore we have developed a protocol for screening, detecting
and treating anxiety and depressive disorders in the perinatal period,
based in international guidelines (NICE) [8] and recent scientific evi-
dence. It was adapted for the Flemish context where perinatal health
care is mainly conducted in general hospitals by obstetricians and
midwives in collaboration with general practitioners. The protocol
takes into account concerns raised by the interdisciplinary task force
about its daily practicability (e.g. time management, false-positive
screening, competence). The perinatal protocol (outlined below) guides
staff through a psychosocial assessment, stepped screening, a clinical
assessment and treatment steps and is currently being implemented
throughout Flanders with support of the Flemish Ministry of Welfare,
Public Health and Family.
2. Psychosocial assessment
Risk factors for perinatal anxiety and depressive disorders include
(familial) psychiatric history, substance abuse, pregnancy complica-
tions, lack of social support, partner violence and (recent) stressful life
events (see Table 1) [1,6,9,10]. Teenagers, socially deprived, refugee
and immigrant women are also more at risk by poor access to perinatal
health care [11].
In order to identify women at risk, a psychosocial assessment is
conducted by midwives, who are granted some extra 30min during the
standard hospital visit at 16 weeks pregnancy. This assessment may also
take place at first contact with any health care professional.
When two or more risk factors or one high risk factor such as sub-
stance abuse, partner violence or a positive family psychiatric history
for bipolar disorder are present, the pregnant women are offered sup-
port for these problems. The psychosocial assessment not only helps to
increase the awareness of mental health problems, it also facilitates
discussion of psychosocial difficulties between the midwives, ob-
stetricians, the women and their partners during subsequent hospital
visits. It destigmatizes mental health problems and increases referral to
specialized mental health services.
3. Stepped screening protocol for depression and anxiety
disorders
The stepped screening protocol (see Fig. 1) starts with brief, vali-
dated, self-report questionnaires for depression (‘Whooley questions’)
and anxiety (‘GAD-2’) [12,13], which reduces the number of women
who need more extensive screening by at least 50% [7]. Both are freely
available in many languages. The Whooley questions (with a negative
predictive value between 93%–100%) show good accuracy for ex-
cluding depressive disorders [7,14].
A positive score on one Whooley question or on both items of the
GAD-2 result in the administration of the Edinburgh (Postnatal)
Depression Scale (E(P)DS) [15]. The E(P)DS shows high sensitivity
(67–100%) and specificity (> 87%) during pregnancy with highest
performance within the 2nd and 3rd trimester [16,17]. A positive score
on the E(P)DS not only indicates a risk for depression, but also for other
psychiatric disorders (likelihood ratio: 6) [2,14]. Finally, a score of five
or more on the items 3, 4 and 5 (e.g. ‘EDS-3A’) is a sensitive detector of
anxiety problems in the perinatal period [18,19] and will automatically
lead to the administration of GAD-7 in our protocol [20].
The stepped screening is conducted by a midwife during the first
ultrasound visit at 20–21 weeks of pregnancy. The 20–25weeks period
is ideal for detecting symptoms of depression and anxiety during
pregnancy [21,22]. Trait anxiety is more prominent in the second tri-
mester than state anxiety, which is highest in the first and third
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trimester [21]. The screening is repeated during the standard postnatal
gynaecological visit at 6 weeks (to avoid any interference with the baby
blues) by the midwives and during the routine medical check-up of the
baby at 6months by the nurses of ‘Child and Family’ [23].
Midwives trained in the assessment and screening are ideally placed
for openly discussing mental health issues, giving some basic psy-
choeducation and motivating women with difficulties for seeking
treatment [24].
4. Clinical assessment and treatment
A score of 13 or more on the E(P)DS or of 15 or more on the GAD-7
points to an increased risk of anxiety and depressive disorders (see
Fig. 1). These women will be referred for further clinical assessment to
the psychiatrist or psychologist working at the maternity services or to
their own GP depending on their preferences.
A low score (< 10 on the E(P)DS or< 9 on the GAD-7) does not
lead to any additional intervention whereas an intermediate score
(10–12 on the E(P)DS or 10–14 on the GAD-7) leads to a repeat
screening at the next visit. A positive score on item 10 of the E(P)DS,
triggers the midwives to explore suicidal risk and refer the women to
specialist care.
After diagnosing a mental illness during clinical assessment, treat-
ment is offered at the maternity service unit in close collaboration with
the midwives, obstetrician, GP and social services [25]. Referral to in-
patient or day-clinic services, mother-baby unit or crisis resolution team
are additional treatment options.
5. Conclusion
Our new protocol for the screening, detection and treatment of
perinatal anxiety and depressive disorders integrated within maternity
services makes mental health care more accessible and less stigmatizing
for both women and their partners. It also helps the perinatal healthcare
workers pay more attention to the psychosocial context of the women
they are seeing. The mental healthcare training the midwives receive
increases their knowledge and skills regarding perinatal mental health.
Although further research will be necessary to examine the cost-effec-
tiveness of this protocol, it is hoped integrating mental health screening
and treatment in standard perinatal care will improve mental health
care for women, their partners and offspring.
Table 1
Risk factors investigated during psychosocial assessment.
Lack of social support Substance abuse
Partner violence (Familial) psychiatric history
Stressful life-events Unwanted pregnancy
Social deprivation Pregnancy complications
Teenage-immigrant-refugee pregnancy
Fig. 1. Stepped screening protocol.
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